BRD2492

CAS No. 1821669-43-5

BRD2492( BRD 2492 )

Catalog No. M12810 CAS No. 1821669-43-5

BRD2492 is a highly potent, selective HDAC1/2 inhibitor (IC50=2/19 nM, respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BRD2492
  • Note
    Research use only, not for human use.
  • Brief Description
    BRD2492 is a highly potent, selective HDAC1/2 inhibitor (IC50=2/19 nM, respectively).
  • Description
    BRD2492 is a highly potent, selective HDAC1/2 inhibitor (IC50=2/19 nM, respectively) that displays excellent selectivity versus HDAC3 (IC50=2.08 uM, ≥110-fold selectivity) and all other HDAC isoforms, increases caspase-3 activation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BRD 2492
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1821669-43-5
  • Formula Weight
    346.39
  • Molecular Formula
    C20H18N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 31.25 mg/mL (90.22 mM)
  • SMILES
    O=C(NC1=CC(C2=CC=NC=C2)=CC=C1N)C3=CC=C(NC(C)=O)C=C3
  • Chemical Name
    4-Acetylamino-N-(2-amino-5-pyridin-4-yl-phenyl)-benzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wagner FF, et al. ACS Chem Biol. 2016 Feb 19;11(2):363-74.
molnova catalog
related products
  • Tucidinostat

    Tucidinostat (Chidamide, HBI-8000, CS055) is a novel histone deacetylase (HDAC) inhibitor.

  • SIS17

    SIS17 is a potent and selective HDAC 11 inhibitor with an IC50 value of 0.83 μM. SIS17 is active in cells and inhibited the demyristoylation of a known HDAC11 substrate serine hydroxymethyl transferase 2 without inhibiting other HDACs.

  • Valproic acid

    A HDAC inhibitor that selectively inhibits the catalytic activity of class I HDACs, and induces proteasomal degradation of HDAC2.